Menu
Recruiting NCT06337214

TCM Therapy Program Impact on Breast Cancer Patients' Vital Energy

No phase Interventional Breast Cancer Neoplasm, Breast Patient Participation Mental Health Issue

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy.
Who it may be relevant to
Registry conditions: Breast Cancer, Neoplasm, Breast, Patient Participation, Mental Health Issue. Basic parameters: 18 years — 85 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Taiwan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Holistic Medical Approach - The Effect of "Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy" on Breast Cancer Patients Undergoing Cancer Therapy

Overview

The goal of this study is to evaluate the impact of the "Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy" on patients with breast cancer who are currently undergoing conventional Western medical treatments in Taiwan. The main questions it aims to answer are: Can the "Traditional Chinese Medicine Therapy Program" alleviate symptoms experienced by breast cancer patients? Does the program improve the quality of life for breast cancer patients receiving Western medical treatments? How does the program contribute to the management of side effects associated with Western oncological therapies? Participants will: Engage in the "Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy" provided by the Taiwan Compassionate Cancer Care Association. Receive supportive and educational services, including auxiliary Chinese medicine treatment courses, lifestyle and health education, and psychological counseling. This study seeks to integrate the concept of holistic healthcare, emphasizing coordinated care that encompasses physical, mental, and social aspects, into the treatment of breast cancer.

Detailed description

This study aims to evaluate whether the participation in Traditional Chinese Medicine (TCM) supportive therapy courses, specifically the "Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy" combined with the use of the herbal formulation at Taipei City Hospital, can enhance the quality of life of breast cancer patients undergoing treatment, increase their understanding and satisfaction with TCM adjunctive treatments, and bolster their confidence in cancer recovery.

This study adopts a holistic healthcare approach, integrating the Traditional Chinese Medicine (TCM) formulation Kuan-Sin-Yin from Taipei City Hospital with the "TCM Therapy Program for Reinforcing Vital Energy" course offered by a cancer patient support organization, to research its effects on breast cancer patients undergoing conventional medical treatment. International standard questionnaires and other inquiries are utilized to evaluate the impact on patients' physical, emotional, spiritual, and social well-being.

Interventions

  • Behavioral Traditional Chinese Medicine Therapy Program for Reinforcing Vital Energy
    Comparing cancer patients who have participated in the program with those who have not, this study will examine differences in two types of quality of life questionnaires and constitution between the two groups.

Primary outcome measures

  • Questionnaire: Constitution in Chinese Medicine Questionnaire [Time frame: Pre-test → Participation in "Traditional Chinese Medicine Program for Reinforcing Vital Energy" or not → Post-test After 4 ~6 weeks]
  • Questionnaire: Functional Assessment of Cancer Therapy-General Scale, FACT-G)(Version 4) [Time frame: Pre-test → Participation in "Traditional Chinese Medicine Program for Reinforcing Vital Energy" or not → Post-test After 4 ~6 weeks]
  • Questionnaire: European Organisation for Research and Treatment of Cancer, EORTC QLQ-BR23) [Time frame: Pre-test → Participation in "Traditional Chinese Medicine Program for Reinforcing Vital Energy" or not → Post-test After 4 ~6 weeks]
Secondary outcome measures (1)
  • Additional questions regarding the "Traditional Chinese Medicine Program for Reinforcing Vital Energy" [Time frame: Pre-test → Participation in "Traditional Chinese Medicine Program for Reinforcing Vital Energy" or not → Post-test After 4 ~6 weeks]

Eligibility criteria

Inclusion criteria

  • Individuals aged 18 years and above and below 85 years, willing to voluntarily participate in the study.
  • Diagnosed with malignant breast tumors, ICD-10: C50, by conventional medicine.
  • Patients currently undergoing cancer treatment, including chemotherapy, radiotherapy, or targeted therapy.

Exclusion criteria

  • Diagnosed solely with carcinoma in situ or benign tumors, including fibrocystic breast conditions, by conventional medicine.
  • Patients regularly receiving Astragalus polysaccharide injections.
  • Patients with a history of allergies to Traditional Chinese Medicine.
  • Pregnant or breastfeeding women.
  • Individuals with a drug addiction habit, including both narcotic and non-narcotic drugs.
  • Any other situation where the participant is unable to cooperate (e.g., due to any factor that prevents participation, deemed unsuitable for participation by study staff, unwillingness to sign the consent form).

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Sequential
Masking
Open label
Primary purpose
Supportive care

Study locations

Taiwan · 1 center
  • Taipei City Hospital — Taipei

Identifiers

NCT: NCT06337214 · TCHIRB-11301014-E

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗